|1.||Sasano, Hironobu: 65 articles (11/2015 - 01/2002)|
|2.||Chen, Shiuan: 54 articles (07/2015 - 04/2002)|
|3.||Suzuki, Takashi: 46 articles (10/2015 - 01/2002)|
|4.||Simpson, Evan R: 40 articles (12/2015 - 01/2002)|
|5.||Miki, Yasuhiro: 40 articles (11/2015 - 01/2005)|
|6.||Bulun, Serdar E: 39 articles (05/2015 - 03/2002)|
|7.||Dowsett, Mitch: 25 articles (01/2015 - 01/2002)|
|8.||Brueggemeier, Robert W: 25 articles (02/2012 - 02/2002)|
|9.||Evans, Dean B: 25 articles (05/2011 - 07/2005)|
|10.||Brodie, Angela: 24 articles (11/2015 - 03/2002)|
|1.||Breast Neoplasms (Breast Cancer)
01/01/2014 - "Substitution of a steroidal for a non-steroidal aromatase inhibitor produced a sustained complete remission in a patient with hormonal receptor-positive postmenopausal recurrent breast cancer. "
01/01/2014 - "We here present a rare case of non-steroidal aromatase inhibitor-tolerant metastatic breast cancer with long-term complete remission following substitution of a steroidal aromatase inhibitor. "
01/01/2014 - "Long-term complete remission of metastatic breast cancer, induced by a steroidal aromatase inhibitor after failure of a non-steroidal aromatase inhibitor."
04/01/2012 - "Concerning aromatase, the application of antiaromatase agents has been largely developed in the treatment of breast cancer patients, with very positive results. "
01/01/2010 - "Aromatase inhibition by anti-aromatase agents is largely used with very positive results in the treatment of breast cancer patients. "
08/01/2005 - "Sensitivity analyses suggest that sequential treatment strategies optimized 10-year disease-free and distant disease-free survival independent of the degree of the beneficial carryover effect after aromatase inhibitor therapy or the ratio of local to distant tumor recurrence. "
10/01/1993 - "Aromatase activity was significantly greater in PR-positive tumors than in PR-negative tumors (p < 0.002). "
11/15/2009 - "Collectively, results from this study provide data to support that HSP90 inhibitors may be an effective therapy to treat aromatase inhibitor-resistant breast cancers and that improved efficacy can be achieved by combined use of a HSP90 inhibitor and an AKT inhibitor."
01/01/2008 - " is a unique case as it illustrates how treatment with an aromatase inhibitor leading to cancer regression can result in an improvement in the paraneoplastic symptoms."
03/01/1996 - "These results suggest that, similar to our previous findings in the breast bearing a tumor, adipose tissue aromatase expression in the disease-free breast is determined by the local ratio of fibroblasts to adipocytes."
11/01/2008 - "To present a case demonstrating lack of efficacy of an aromatase inhibitor in treating ureteral endometriosis. "
01/01/2015 - "The purpose of this study was to assess the impact of 3 months of aromatase inhibition together with progestin add-back on ovarian endometrioma size. "
01/01/2007 - "This study investigated whether polymorphisms of the CYP19 gene are associated with the risk of advanced endometriosis in Korean women. "
08/01/2006 - "The aim of the present study was to measure the in vitro aromatase activity in granulosa cells of women with endometriosis submitted to assisted reproduction techniques. "
08/01/2002 - "For ovarian endometrioma, previous studies have been conducted ex vivo using cells obtained from endometrioma and have demonstrated that steroidogenic factor-1 is involved in the expression of aromatase. "
01/01/2009 - "Previous studies showed statistically significant correlation between results of immnuohistochemistry and biochemical analysis in carcinoma components stained by aromatase monoclonal antibody 677. "
08/01/2012 - "Therefore, in this study, we evaluated the aromatase expression in colon carcinoma using immunohistochemistry and real-time polymerase chain reaction. "
07/04/2011 - "However, at least at this juncture, further studies should be required to establish an aromatase inhibitor treatment as one form of endocrine therapy of ovarian carcinoma in future."
02/01/2011 - "In the current study, MCF-7aro and T47Daro aromatase transfected breast carcinoma cells were used to explore the mechanisms of post-transcriptional regulation of aromatase activity by growth factor pathways. "
07/01/2008 - "This review summarizes the results of recent studies on the expression and regulation of aromatase in breast carcinoma tissues, and discusses the potential biological and/or clinical significance of aromatase. "
10/01/2009 - "With the exception of an aromatase inhibitor used alone, the antalgic effect of the considered medical therapies was high for the entire treatment period (from 6 to 12 months), with 60-90% of patients reporting considerable reduction or complete relief from pain symptoms. "
11/01/2014 - "In this study we have assessed whether aromatase expression in the dorsal horns of the spinal cord is altered in a rat model of central pain syndrome, induced by the unilateral electrolytic lesion of the spinothalamic tract. "
10/01/2007 - "Aromatase inhibitor-associated pain is more frequent in patients not in clinical trials than previously appreciated in clinical trials. "
06/01/2007 - "In the major adjuvant aromatase inhibitor clinical trials, 25%-30% of the patients enrolled experienced musculoskeletal pain. "
02/06/2008 - "She developed an increase of her diffuse pain syndrome and joint aches after the introduction of an aromatase inhibitor. "
|8.||Estrogen Receptor Modulators (Antiestrogen)
|1.||Heterologous Transplantation (Xenotransplantation)
|2.||Drug Therapy (Chemotherapy)